EBMT expert consensus guideline on allogeneic HCT for myelodysplastic/myeloproliferative neoplasms (excluding CMML): proposes remission criteria and suggestions for managing poor graft function, splenomegaly and post-transplant relapse.
Guideline
Armstrong et al. Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee